Pigmentation comes up in nearly every consultation. It is one of the most common skin concerns among patients in the UAE, across all ages, skin types, and backgrounds. And yet it is also one of the areas where patients have tried the most products with the least satisfying results.
Part of the reason: not all pigmentation is the same. Treating sun-induced dark spots with the same approach as hormonal melasma will not work. Understanding the type of pigmentation you have is the starting point for treating it effectively.
What Is Hyperpigmentation?
Hyperpigmentation is a broad term for areas of skin that appear darker than the surrounding skin. It occurs when melanocytes - the cells responsible for producing melanin - become overactive in a particular area, depositing more pigment than the surrounding skin produces.
The underlying trigger matters enormously. Common causes include:
- Sun exposure (solar lentigines): Chronic UV exposure stimulates melanin production as a protective response. The result is darkening of previously sun-exposed areas, particularly the face, hands, and arms.
- Hormonal changes (melasma): Common in women during pregnancy, while taking oral contraceptives, or with hormonal shifts. Melasma appears as larger, patterned patches, often on the forehead, cheeks, and upper lip. It is notoriously difficult to treat and prone to recurrence.
- Post-inflammatory hyperpigmentation (PIH): Skin that has been inflamed or injured - from acne, a cut, an eczema flare, or even an aggressive skincare product - often leaves a dark mark afterward. This is PIH, and it is especially common in medium to darker skin tones.
Why Pigmentation Is Particularly Common in the UAE
The UAE's combination of intense, year-round UV exposure and a population with a high proportion of medium to darker skin tones makes hyperpigmentation one of the most prevalent dermatological concerns in this region.
Darker skin tones contain more melanin and melanocytes that are more reactive - which is protective against sun damage but also means that any form of inflammation or UV exposure is more likely to trigger pigmentation. Post-inflammatory hyperpigmentation in particular is significantly more visible and persistent in Fitzpatrick skin types IV through VI (medium brown to dark brown).
Patients who have both high sun exposure and a history of acne face a compounded challenge: acne causes inflammation, inflammation causes PIH, and sun exposure deepens and prolongs that PIH. Treating only the acne without addressing both triggers simultaneously produces limited results.
What Actually Works
There is no shortage of products claiming to fade pigmentation. Most over-the-counter options have limited evidence. Some have evidence but inadequate concentrations in their commercially available formulations. A few work genuinely well, particularly when used consistently and in combination with rigorous sun protection.
Topical Treatments
Ingredients with strong clinical evidence for treating hyperpigmentation include:
- Azelaic acid: Anti-inflammatory, inhibits melanin synthesis, particularly useful for PIH and rosacea-associated pigmentation. Well-tolerated across skin types.
- Tranexamic acid: Growing evidence for melasma in particular. Available in both topical and oral forms; prescription oral tranexamic acid has significant clinical support.
- Niacinamide: Reduces the transfer of melanin to skin cells, reduces inflammation, and is well-tolerated even in sensitive skin.
- Retinoids: Increase cell turnover, which gradually fades pigmented cells toward the surface. Require consistent use and careful sun protection given their photosensitizing effect.
- Hydroquinone: A well-studied depigmenting agent. Prescription-strength formulations are more effective than OTC versions, but long-term use requires monitoring and is typically cycled on and off.
In-Clinic Treatments
For moderate to significant pigmentation, topical treatments alone may be insufficient. In-clinic options include:
- Chemical peels: Medically-formulated peels that accelerate cell turnover and reduce pigmentation. Peel selection depends heavily on skin type - the wrong peel on darker skin can cause worsening of PIH.
- Laser treatments: Various wavelengths target melanin. Results are good for solar lentigines; melasma requires a much more careful approach as certain laser protocols can trigger rebound pigmentation in susceptible patients.
- Mesotherapy: Targeted delivery of brightening and antioxidant compounds into the skin can complement topical and laser approaches.
The Role of Sun Protection in Treatment
This cannot be overstated: any pigmentation treatment will produce significantly worse results - or no lasting results at all - without rigorous daily sun protection. UV exposure continues to stimulate melanin production regardless of what treatment is being applied. SPF 50 broad-spectrum sunscreen, used every morning and reapplied where relevant, is not optional during pigmentation treatment. It is the foundation.
What Patients Should Know Before Starting Treatment
Pigmentation responds slowly. Even with the right treatment, meaningful visible improvement typically takes weeks to months. Patients who expect rapid results often discontinue treatment prematurely or escalate to more aggressive interventions before their current approach has had time to work.
The other key point: treatment has to match the type of pigmentation. Treating melasma the same way you treat a post-acne dark spot does not work well. A dermatology consultation to identify the type and trigger of your pigmentation is the most efficient first step - it saves both time and money compared to working through products independently.